{
  "main_header": {
    "sid": 1156969,
    "name": "Lineage Cell Therapeutics, Inc.",
    "stock_name": "Lineage Cell Therapeutics, Inc.",
    "full_name": "Lineage Cell Therapeutics, Inc.",
    "name_url": "stocks-analysis/lineage-cell-therapeutics-inc",
    "exchange": 215,
    "exchangecode": "ASE",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.74",
    "chg": 0.06,
    "chgp": "3.57%",
    "dir": 1,
    "prev_price": "1.68",
    "mcapval": "283.16",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US53566P1093",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "115.01 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lineage-cell-therapeutics-inc-1156969-215&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Lineage Cell Therapeutics Hits New 52-Week High of $2.09",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lineage-cell-therapeutics-hits-new-52-week-high-of-209-3671455",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LineageCellTher_priceRelatedfactors_3671455.png",
        "date": "2025-11-04 17:45:24",
        "description": "Lineage Cell Therapeutics, Inc. achieved a new 52-week high of USD 2.09 on November 3, 2025, reflecting a significant increase from its low of USD 0.37. With a market cap of USD 283 million, the company operates in the Pharmaceuticals & Biotechnology sector, showcasing notable performance metrics."
      },
      {
        "title": "Lineage Cell Therapeutics Hits New 52-Week High of $1.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lineage-cell-therapeutics-hits-new-52-week-high-of-195-3667246",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LineageCellTher_priceRelatedfactors_3667246.png",
        "date": "2025-11-03 17:00:08",
        "description": "Lineage Cell Therapeutics, Inc. achieved a new 52-week high of USD 1.95 on October 31, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen a 144.59% increase over the past year, despite being loss-making and not offering dividends."
      },
      {
        "title": "Lineage Cell Therapeutics Hits New 52-Week High of $1.87",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lineage-cell-therapeutics-hits-new-52-week-high-of-187-3661882",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/LineageCellTher_priceRelatedfactors_3661882.png",
        "date": "2025-10-31 16:00:40",
        "description": "Lineage Cell Therapeutics, Inc. achieved a new 52-week high of USD 1.87 on October 30, 2025, reflecting strong performance in the pharmaceuticals and biotechnology sector. The company has seen a 134.39% increase over the past year, despite being loss-making and lacking a dividend yield."
      },
      {
        "title": "Lineage Cell Therapeutics Hits New 52-Week High of $1.85",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lineage-cell-therapeutics-hits-new-52-week-high-of-185-3622736",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/LineageCellTher_priceRelatedfactors_3622736.png",
        "date": "2025-10-15 16:44:58",
        "description": "Lineage Cell Therapeutics, Inc. has achieved a new 52-week high of USD 1.85, reflecting a significant year-over-year performance increase. With a market capitalization of USD 283 million, the company operates in a competitive biotechnology sector, reporting a negative return on equity and a unique financial structure."
      },
      {
        "title": "Lineage Cell Therapeutics Hits New 52-Week High of $1.82",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lineage-cell-therapeutics-hits-new-52-week-high-of-182-3607956",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/LineageCellTher_priceRelatedfactors_3607956.png",
        "date": "2025-10-09 19:58:59",
        "description": "Lineage Cell Therapeutics, Inc. achieved a new 52-week high of USD 1.82 on October 8, 2025, reflecting a significant one-year performance increase. With a market capitalization of USD 283 million, the company faces challenges, including a negative return on equity and a high price-to-book ratio, while operating in the biotechnology sector."
      },
      {
        "title": "Lineage Cell Therapeutics Hits New 52-Week High of $1.72",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lineage-cell-therapeutics-hits-new-52-week-high-of-172-3579326",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/LineageCellTher_priceRelatedfactors_3579326.png",
        "date": "2025-09-29 14:14:26",
        "description": "Lineage Cell Therapeutics, Inc. has achieved a new 52-week high, highlighting its strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen a significant increase in value over the past year, attracting attention for its innovative approaches despite being a loss-making entity."
      },
      {
        "title": "Lineage Cell Therapeutics Hits New 52-Week High of $1.64",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lineage-cell-therapeutics-hits-new-52-week-high-of-164-3565209",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/LineageCellTher_priceRelatedfactors_3565209.png",
        "date": "2025-09-24 13:13:29",
        "description": "Lineage Cell Therapeutics, Inc. has achieved a new 52-week high, reflecting a significant rise in its stock performance over the past year. With a market capitalization of USD 283 million, the company operates in the Pharmaceuticals & Biotechnology sector, despite facing challenges such as ongoing losses and a negative return on equity."
      },
      {
        "title": "Lineage Cell Therapeutics Hits New 52-Week High of $1.63",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lineage-cell-therapeutics-hits-new-52-week-high-of-163-3559280",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/LineageCellTher_priceRelatedfactors_3559280.png",
        "date": "2025-09-23 15:26:33",
        "description": "Lineage Cell Therapeutics, Inc. achieved a new 52-week high of USD 1.63 on September 22, 2025, reflecting a 106.37% increase over the past year. With a market capitalization of USD 283 million, the company continues to face challenges, including a negative return on equity and a high price-to-book ratio."
      },
      {
        "title": "Is Lineage Cell Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lineage-cell-therapeutics-inc-technically-bullish-or-bearish-3545370",
        "imagepath": "",
        "date": "2025-09-20 19:10:01",
        "description": "As of 10 September 2025, the technical trend for Lineage Cell Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, supported by bullish signals from the Bollinger Bands and daily moving averages. However, the weekly RSI remains bearish, indicating some short-term weakness. The company has significantly outperformed the S&P 500 across multiple periods, with a year-to-date return of 208.46% compared to the S&P 500's 12.22%. Overall, the current technical stance is bullish, with strong indicators driving this sentiment...."
      }
    ],
    "total": 16,
    "sid": "1156969",
    "stock_news_url": "https://www.marketsmojo.com/news/lineage-cell-therapeutics-inc-1156969"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Lineage Cell Therapeutics Hits New 52-Week High of $2.09

2025-11-04 17:45:24

Lineage Cell Therapeutics, Inc. achieved a new 52-week high of USD 2.09 on November 3, 2025, reflecting a significant increase from its low of USD 0.37. With a market cap of USD 283 million, the company operates in the Pharmaceuticals & Biotechnology sector, showcasing notable performance metrics.

Read More

Lineage Cell Therapeutics Hits New 52-Week High of $1.95

2025-11-03 17:00:08

Lineage Cell Therapeutics, Inc. achieved a new 52-week high of USD 1.95 on October 31, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen a 144.59% increase over the past year, despite being loss-making and not offering dividends.

Read More

Lineage Cell Therapeutics Hits New 52-Week High of $1.87

2025-10-31 16:00:40

Lineage Cell Therapeutics, Inc. achieved a new 52-week high of USD 1.87 on October 30, 2025, reflecting strong performance in the pharmaceuticals and biotechnology sector. The company has seen a 134.39% increase over the past year, despite being loss-making and lacking a dividend yield.

Read More

Lineage Cell Therapeutics Hits New 52-Week High of $1.85

2025-10-15 16:44:58

Lineage Cell Therapeutics, Inc. has achieved a new 52-week high of USD 1.85, reflecting a significant year-over-year performance increase. With a market capitalization of USD 283 million, the company operates in a competitive biotechnology sector, reporting a negative return on equity and a unique financial structure.

Read More

Lineage Cell Therapeutics Hits New 52-Week High of $1.82

2025-10-09 19:58:59

Lineage Cell Therapeutics, Inc. achieved a new 52-week high of USD 1.82 on October 8, 2025, reflecting a significant one-year performance increase. With a market capitalization of USD 283 million, the company faces challenges, including a negative return on equity and a high price-to-book ratio, while operating in the biotechnology sector.

Read More

Lineage Cell Therapeutics Hits New 52-Week High of $1.72

2025-09-29 14:14:26

Lineage Cell Therapeutics, Inc. has achieved a new 52-week high, highlighting its strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen a significant increase in value over the past year, attracting attention for its innovative approaches despite being a loss-making entity.

Read More

Lineage Cell Therapeutics Hits New 52-Week High of $1.64

2025-09-24 13:13:29

Lineage Cell Therapeutics, Inc. has achieved a new 52-week high, reflecting a significant rise in its stock performance over the past year. With a market capitalization of USD 283 million, the company operates in the Pharmaceuticals & Biotechnology sector, despite facing challenges such as ongoing losses and a negative return on equity.

Read More

Lineage Cell Therapeutics Hits New 52-Week High of $1.63

2025-09-23 15:26:33

Lineage Cell Therapeutics, Inc. achieved a new 52-week high of USD 1.63 on September 22, 2025, reflecting a 106.37% increase over the past year. With a market capitalization of USD 283 million, the company continues to face challenges, including a negative return on equity and a high price-to-book ratio.

Read More

Is Lineage Cell Therapeutics, Inc. technically bullish or bearish?

2025-09-20 19:10:01

As of 10 September 2025, the technical trend for Lineage Cell Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, supported by bullish signals from the Bollinger Bands and daily moving averages. However, the weekly RSI remains bearish, indicating some short-term weakness. The company has significantly outperformed the S&P 500 across multiple periods, with a year-to-date return of 208.46% compared to the S&P 500's 12.22%. Overall, the current technical stance is bullish, with strong indicators driving this sentiment....

Read More

View All News